Showing results (111-120 of 329) with videos related to

Sort By:
Pageof 33
American Journal of Rhinology & Allergy|April 9, 2013
Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitisEli O Meltzer, David I Bernstein, Bruce M Prenner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adultsPatricia L Winokur, Theresa E Hegmann, Wendy A Keitel, et al.
Vaccine|November 16, 2004
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjectsMark R Schleiss, David I Bernstein, Murray Passo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2023
Anaphylaxis in Clinical Trials of Sublingual Immunotherapy TabletsHendrik Nolte, Moisés A Calderon, David I Bernstein, et al.
Pediatrics|January 24, 2019
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young WomenChelse Spinner, Lili Ding, David I Bernstein, et al.
The Science of the Total Environment|October 20, 2006
The effect of home characteristics on dust antigen concentrations and loads in homesSeung-Hyun Cho, Tiina Reponen, David I Bernstein, et al.
Plos One|March 28, 2019
Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trialsDavid I Bernstein, Rhonda D Cardin, Derek A Pullum, et al.
Vaccine|September 16, 2022
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein GBrent A Stanfield, Fernando J Bravo, David A Dixon, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2019
Understanding differences in allergen immunotherapy products and practices in North America and EuropeVera Mahler, Robert E Esch, Jörg Kleine-Tebbe, et al.
Vaccine|November 26, 2018
The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpesDavid I Bernstein, Derek A Pullum, Rhonda D Cardin, et al.
Pageof 33